Market Influences That Drive Equities Forward: Research Report on Advaxis, Barnwell, MRV, Navidea and Boston Scientific

NEW YORK, December 16, 2014 /PRNewswire/ --

Moments ago, Realtime Equities released new analyst updates concerning several important developing situations. Realtime Equities is the leader in realtime news, commentary and analysis - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.

To access our full PDF reports on a complementary basis, please visit the links at the bottom.

--

Analyst Update: Drug Filing,Quarterly Earnings,Leadership Changes, andStudy Results
Reviewed by: Rohit Tuli, CFA®

The U.S. market on Monday ended the day in red as plummeting oil prices continued to dent investor confidence. The Dow Jones Industrial Average finished at 17,180.84, down 0.58%, the NASDAQ Composite closed at 4,605.16, down 1.04%, and S&P 500 finished the session 0.63% lower at 1,989.63.  Investors remained on the edge ahead of U.S. Federal Reserve meeting scheduled on Wednesday, where it is expected to issue a statement which could signal that the Federal Reserve is close to raising interest rates. The Asian markets on December 15, 2014 ended on a negative note led by continued weakness in global oil prices. The European stock markets plunged with slumping oil prices, while Russian stocks and the ruble dropped with rising concerns about the Russian economy.

Advaxis, Inc. (Advaxis) announced that the US drug regulator has accepted its Investigational New Drug (IND) application to conduct a Phase 1/2 clinical study of ADXS-HPV alone or in combination with MedImmune's investigational anti-PD-L1 immune checkpoint inhibitor for treatment of HPV-associated cancers. Click on the report below to know more about Advaxis' investigational drug.

Shares of Honolulu-based Barnwell Industries, Inc. (Barnwell) jumped over 7% on Monday, December 15, after the Company said it has lifted its bottom-line back into the black in fourth quarter and full-year 2014. Barnwell said it earned $0.7 million in FY 2014, compared to net loss of $8.6 million in the previous fiscal. Find out what has helped Barnwell mark a significant turnaround in its profitability in FY 2014, along with management's viewpoint.

MRV Communications, Inc. (MRV) has announced a couple of changes in its top management. MRV said that it has appointed Mark J. Bonney as its new President and CEO, and Stephen Krulik as the new CFO, effective December 15, 2014. Click on the report below to find out more about the MRV's leadership changes.

Shares of Navidea Biopharmaceuticals Inc. (Navidea) gained over 4% on Monday, December 15, after the Company announced that a data presented by independent academic collaborators at a conference highlighted ability of Novel Manocept™ Immunotherapy to kill activated macrophages from KS patients. Click on the report below to find out detailed view of the presentations at the conference.

Boston Scientific Corporation (Boston Scientific) reported that a new data evaluating the Company's Precision Spectra™ Spinal Cord Stimulator (SCS) System demonstrate that the device provided sustained, highly significant relief of low back pain 12 months after implantation. Find out more about the Boston Scientific's Spinal Cord Stimulator (SCS) System by clicking on the report below.

--

Today's update concerns the following companies:

============

Full PDF Download Links (you may have to copy and paste the following links into your browser):

ADXSResearchReport: ( http://get.realtimeequities.com/pdf/?c=Advaxis&d=16-Dec-2014&s=ADXS ),

BRNResearchReport: ( http://get.realtimeequities.com/pdf/?c=Barnwell&d=16-Dec-2014&s=BRN ),

MRVC Research Report: ( http://get.realtimeequities.com/pdf/?c=MRV%20Communications&d=16-Dec-2014&s=MRVC ),

NAVB Research Report: ( http://get.realtimeequities.com/pdf/?c=Navidea&d=16-Dec-2014&s=NAVB ),

BSX Research Report: ( http://get.realtimeequities.com/pdf/?c=Boston%20Scientific&d=16-Dec-2014&s=BSX ).

============

--

About Realtime Equities  

Tired of missing trades? In a world where information travels at the speed of light, you can't afford to be out of touch. Get an actionable source of information. Find the best opportunities available in real-time. Don't waste time trying to chase the news, get ahead of it with Realtime Equities. We find information as it happens and send it out to our subscribers in our e-alerts. Our focus is to find companies positioned to see upward momentum, delivering alerts to your inbox as the event unfolds in realtime. Join us in our battle to beat the markets, you'll be happy you did.

We are proud to serve professional traders, financial advisors, hedge funds and experience individual investors including some of the top firms on wall-street today. For more information about our service offerings and subscriptions, please visit our website or reach out to our sales staff. Advanced subscription packages are available to qualifying institutional clients and accredited investors, please speak with your account manager to learn more about these custom opportunities.

If you enjoyed today's content, subscribe to our live updates here: ( http://get.realtimeequities.com/updates )

--

Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Realtime Equities, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Realtime Equities in this article or report according to the procedures outlined by Realtime Equities. Realtime Equities is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.realtimeequities.com/editors

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE RealtimeEquities.com